FDA Head Commits to Following Pending Abortion Pill Court Orders

The FDA plans to follow any court rulings on the abortion pill mifepristone, the agency’s head said Wednesday while also highlighting the potential dangers of a lower court injunction that sits before the Supreme Court.

“FDA intends to comply with any court orders,” Food and Drug Administration Commissioner Robert M. Califf told members of a Senate Appropriations subcommittee in a hearing on the FDA’s fiscal 2024 budget request. The commitment was in response to a question from the subcommittee’s ranking member, Sen. John Hoeven (R-N.D.).

Califf’s remarks came shortly before the Supreme Court extended a temporary hold on court-ordered mifepristone ...